STAA (Staar Surgical Co) Current Accrued Expense: $14.9 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STAA Staar Surgical Co STAA
80 GF Score
Price $24.09
GF Value $33.49
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Staar Surgical Co Current Accrued Expense?

Staar Surgical Co STAA -8.02% 80 Current Accrued Expense is $14.9 Mil as of Jun. 2026. GuruFocus rates STAA with a GF Score™ of 80/100 and a GF Value™ of $33.49 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Staar Surgical Co's Current Accrued Expense for the quarter that ended in Jun. 2026 was $14.9 Mil.

Staar Surgical Co's quarterly Current Accrued Expense declined from Dec. 2025 ($14.7 Mil) to Mar. 2026 ($11.5 Mil) but then increased from Mar. 2026 ($11.5 Mil) to Jun. 2026 ($14.9 Mil).

Staar Surgical Co's annual Current Accrued Expense increased from Dec. 2023 ($14.8 Mil) to Dec. 2024 ($18.8 Mil) but then declined from Dec. 2024 ($18.8 Mil) to Dec. 2025 ($14.7 Mil).

Staar Surgical Co Current Accrued Expense Related Terms

Staar Surgical Co Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Staar Surgical Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staar Surgical Co Current Accrued Expense Chart

Staar Surgical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.03 10.86 14.83 18.84 14.66

Staar Surgical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.93 13.60 14.66 11.51 14.88
STAA
80GF Score
Staar Surgical Co STAA
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Staar Surgical Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $14.9 Mil mean?
Staar Surgical Co (STAA) has a Current Accrued Expense of $14.9 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Staar Surgical Co and its competitors.
Is Staar Surgical Co's Current Accrued Expense too high?
Staar Surgical Co's current Current Accrued Expense is $14.9 Mil. Overall, Staar Surgical Co has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's Current Accrued Expense compare to KMTS and AZTA?
Staar Surgical Co's Current Accrued Expense of $14.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Staar Surgical Co and its competitors. Staar Surgical Co's current Current Accrued Expense is $14.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Modestly Undervalued. The stock's GF Value™ is $33.49, compared to a current price of $24.09 — trading 28.1% below its estimated fair value. The current Current Accrued Expense is $14.9 Mil. Staar Surgical Co's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current Current Accrued Expense is $14.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Staar Surgical Co (STAA) Overvalued in 2026?

Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued. The current stock price of $24.09 is trading 28.1% below its estimated GF Value™ of $33.49. GuruFocus considers Staar Surgical Co to be Modestly Undervalued.

Key valuation signals for STAA:

  • Current Accrued Expense: $14.9 Mil
  • GF Value™: $33.49 vs. price of $24.09 (28.1% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Staar Surgical Co Business Description

Other Exchanges SR3:Germany
Address 25510 Commercentre Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
80GF Score

Get the complete analysis for STAA

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.09
Price
$33.49
GF Value